These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 8289984

  • 1. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
    Moreau R, Gaudin C, Hadengue A, Braillon A, Roulot D, Bacq Y, Lebrec D.
    Nephron; 1993; 65(3):359-63. PubMed ID: 8289984
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased cerebrovascular resistance in cirrhotic patients with ascites.
    Guevara M, Bru C, Ginès P, Fernández-Esparrach G, Sort P, Bataller R, Jiménez W, Arroyo V, Rodés.
    Hepatology; 1998 Jul; 28(1):39-44. PubMed ID: 9657094
    [Abstract] [Full Text] [Related]

  • 5. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L, Martin PY, Giostra E, Niederberger M, Lang U, Capponi A, Hadengue A.
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A, Moreau R, Bacq Y, Gaudin C, Braillon A, Lebrec D.
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [Abstract] [Full Text] [Related]

  • 9. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C.
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [Abstract] [Full Text] [Related]

  • 10. [Physiopathology of nephropathy in liver cirrhosis. Pathogenetic role of ascites and of inferior vena cava pressure increase].
    Gatta A, Zuin R, Merkel C, Milani L, Ruol A.
    Minerva Dietol Gastroenterol; 1979 Nov; 25(1):9-16. PubMed ID: 450267
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
    Woitas RP, Flommersfeld S, Stoffel-Wagner B, Schiedermaier P, Brensing KA, Spengler U, Sauerbruch T.
    Scand J Gastroenterol; 2002 Nov; 37(11):1321-7. PubMed ID: 12465732
    [Abstract] [Full Text] [Related]

  • 13. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.
    Kimer N, Pedersen JS, Busk TM, Gluud LL, Hobolth L, Krag A, Møller S, Bendtsen F, Copenhagen Rifaximin (CoRif) Study Group.
    Hepatology; 2017 Feb; 65(2):592-603. PubMed ID: 27775818
    [Abstract] [Full Text] [Related]

  • 14. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
    MacGilchrist A, Craig KJ, Hayes PC, Cumming AD.
    Clin Sci (Lond); 1994 Sep; 87(3):329-35. PubMed ID: 7525142
    [Abstract] [Full Text] [Related]

  • 15. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.
    Krag A, Bendtsen F, Henriksen JH, Møller S.
    Gut; 2010 Jan; 59(1):105-10. PubMed ID: 19837678
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure.
    Moreau R, Pussard E, Brenard R, Gaudin C, Berdeaux A, Lebrec D.
    J Hepatol; 1991 Nov; 13(3):351-7. PubMed ID: 1839683
    [Abstract] [Full Text] [Related]

  • 18. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F, Raina N, Richardson R.
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.